Australia markets closed

MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.07-1.12 (-4.85%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
77,872
64,188
60,121
157,742
91,880
Operating expenses
Research development
203,054
195,309
190,827
147,232
122,091
Selling general and administrative
44,172
46,064
40,500
32,653
29,831
Total operating expenses
247,226
241,373
231,327
179,885
151,922
Operating income or loss
-169,354
-177,185
-171,206
-22,143
-60,042
Total other income/expenses net
2,718
25,374
-247
2,517
1,514
Income before tax
-166,636
-151,811
-171,453
-19,626
-58,528
Income from continuing operations
-166,636
-151,811
-171,453
-19,626
-58,528
Net income
-166,636
-151,811
-171,453
-19,626
-58,528
Net income available to common shareholders
-166,636
-151,811
-171,453
-19,626
-58,528
Basic EPS
-
-3.16
-4.19
-0.54
-1.69
Diluted EPS
-
-3.16
-4.19
-0.54
-1.69
Basic average shares
-
48,083
40,925
36,095
34,685
Diluted average shares
-
48,083
40,925
36,095
34,685
EBITDA
-
-166,340
-162,927
-14,915
-52,434